Truist Financial’s Sorrento Therapeutics, Inc. SRNE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-22,650
Closed -$20.1K 2716
2022
Q4
$20.1K Hold
22,650
﹤0.01% 2533
2022
Q3
$36K Hold
22,650
﹤0.01% 2479
2022
Q2
$45K Buy
+22,650
New +$39.2K ﹤0.01% 2586
2021
Q4
Sell
-13,001
Closed -$99K 2886
2021
Q3
$99K Sell
13,001
-23,700
-65% -$201K ﹤0.01% 2644
2021
Q2
$355K Buy
36,701
+4,600
+14% +$36.6K ﹤0.01% 2271
2021
Q1
$265K Sell
32,101
-4,895
-13% -$51.7K ﹤0.01% 2363
2020
Q4
$253K Sell
36,996
-4,150
-10% -$33.3K ﹤0.01% 2263
2020
Q3
$459K Sell
41,146
-9,275
-18% -$84.9K ﹤0.01% 1772
2020
Q2
$317K Buy
+50,421
New +$193K ﹤0.01% 1913

Other funds holding SRNE